Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway

A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation throug...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 25; no. 15; p. 8235
Main Authors Chen, Yung-Lung, Wang, Hui-Ting, Lee, Wen-Chin, Lin, Pei-Ting, Liu, Wen-Hao, Hsueh, Shu-Kai
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells.
AbstractList A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells.
A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells.A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) in H9C2 cells. This study tested whether empagliflozin could prevent HG-induced mitochondria fragmentation through this pathway. We found that exposing H9C2 cells to an HG concentration decreased cell viability and increased cell apoptosis and caspase-3. Empagliflozin could reverse the apoptosis effect of HG stimulation on H9C2 cells. In addition, the HG condition caused mitochondria fragmentation, which was reduced by empagliflozin. The expression of mitochondria fission protein was upregulated, and fusion proteins were downregulated under HG stimulation. The expression of fission proteins was decreased under empagliflozin treatment. Increased calcium accumulation was observed under the HG condition, which was decreased by empagliflozin. The increased expression of ERK 1/2 under HG stimulation was also reversed by empagliflozin. Our study shows that empagliflozin could reverse the HG condition, causing a calcium-dependent activation of the ERK 1/2 pathway, which caused mitochondria fragmentation in H9C2 cells.
Audience Academic
Author Wang, Hui-Ting
Lee, Wen-Chin
Liu, Wen-Hao
Lin, Pei-Ting
Hsueh, Shu-Kai
Chen, Yung-Lung
Author_xml – sequence: 1
  givenname: Yung-Lung
  orcidid: 0000-0001-7465-0880
  surname: Chen
  fullname: Chen, Yung-Lung
– sequence: 2
  givenname: Hui-Ting
  surname: Wang
  fullname: Wang, Hui-Ting
– sequence: 3
  givenname: Wen-Chin
  orcidid: 0000-0001-6172-1483
  surname: Lee
  fullname: Lee, Wen-Chin
– sequence: 4
  givenname: Pei-Ting
  orcidid: 0000-0002-8474-4976
  surname: Lin
  fullname: Lin, Pei-Ting
– sequence: 5
  givenname: Wen-Hao
  surname: Liu
  fullname: Liu, Wen-Hao
– sequence: 6
  givenname: Shu-Kai
  surname: Hsueh
  fullname: Hsueh, Shu-Kai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39125805$$D View this record in MEDLINE/PubMed
BookMark eNptkk1v1DAQhiNURD_gxhlZ4sKBtI6deJPjKmy7FUVUFM6R155kvXLsYDuF9h_2X-GQVpSq8mEs63nfmfHMYbJnrIEkeZvhY0orfKJ2vSdFVpSEFi-SgywnJMWYLfYe3feTQ-93GBNKiupVsk-rjBQlLg6Su1U_8E6rVttbZdClg2swAa1Vt03P9CisB3QVVD9qHpQ16NzIUSjToeVgh2C98ogbib6oYMXWGukUR6eOd310mRXRdV3VBNWgtUdh6-zYbWMEVHMt1Ninn2AAI6e0SxHU9Sxb_Q6Oi6iJmR26Up3hOv0G3VQISPRZGR5Ly04IuuRh-4vfvE5etlx7eHMfj5Ifp6vv9Tq9-Hp2Xi8vUpGTPKQZ28gccI454RSzospYu6BSMqAtg2qRi4IAZbQCRlrCCGBJC7apZMmpoOWGHiUfZt_B2Z8j-ND0yk-FcgN29A3F8XPLkpVVRN8_QXd2dLGRvxSucrog5B_VcQ2NMq2dOp9Mm2WJ8yKLYywjdfwMFY-EXom4Eq2K7_8J3t0nHzc9yGZwqufupnmYfQTIDAhnvXfQNkLNM4vOSjcZbqYFax4vWBR9fCJ68H0W_wNRtdK0
CitedBy_id crossref_primary_10_1007_s11255_025_04443_z
Cites_doi 10.3390/antiox10081223
10.14814/phy2.13741
10.1089/ars.2010.3284
10.1016/j.biopha.2021.112455
10.1016/j.jacc.2019.11.031
10.1186/s12933-022-01532-6
10.3892/ijmm.2012.1186
10.3390/cells8091085
10.1007/s00125-018-4670-7
10.1152/ajprenal.00565.2018
10.3390/cells11193107
10.3390/ijms232213816
10.1056/NEJMoa2022190
10.1016/j.bbrc.2019.03.193
10.1038/s41598-020-76698-8
10.1002/advs.202100275
10.3389/fphys.2020.00252
10.1056/NEJMoa1811744
10.1016/j.diabres.2019.107843
10.1016/S0898-6568(02)00007-4
10.3390/ijms20071680
10.1056/NEJMoa1611925
10.1186/s12933-023-01756-0
10.1056/NEJMoa1504720
10.1007/s11886-019-1165-1
10.3389/fcvm.2022.859253
10.1111/jcmm.13975
10.1155/2022/1122494
10.1007/s10741-020-10024-2
10.1056/NEJMoa2024816
10.1002/jcp.27597
10.3389/fcvm.2023.1005408
10.1056/NEJMoa1515920
10.1007/s00125-019-05039-w
10.1016/j.metabol.2020.154334
10.3390/cells9071662
10.1016/j.cellsig.2019.109506
10.1046/j.1523-1755.1998.00868.x
10.1016/j.kint.2020.06.019
10.1038/s41569-020-0406-8
10.1124/pr.115.011502
ContentType Journal Article
Copyright COPYRIGHT 2024 MDPI AG
2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2024 MDPI AG
– notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
DOI 10.3390/ijms25158235
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection (ProQuest)
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Medical Database
ProQuest research library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID A804511428
39125805
10_3390_ijms25158235
Genre Journal Article
GeographicLocations United States
Taiwan
GeographicLocations_xml – name: Taiwan
– name: United States
GrantInformation_xml – fundername: Kaohsiung Chang Gung Memorial Hospital
  grantid: CMRPG8K1391, CMRPG8K1392, CMRPG8K1393
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
PMFND
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c424t-16bd4e040a2a3065916f73dd6e3f6e974c52e3639e62f262e0d356b9d8a3c38b3
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Fri Jul 11 06:57:48 EDT 2025
Fri Jul 25 22:45:11 EDT 2025
Tue Jun 17 22:04:20 EDT 2025
Tue Jun 10 21:01:55 EDT 2025
Wed Feb 19 02:06:59 EST 2025
Tue Jul 01 01:43:42 EDT 2025
Thu Apr 24 22:57:28 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Keywords empagliflozin
high-glucose stimulation
H9C2
mitochondria fragmentation
calcium-dependent
extracellular signal-regulated kinase 1/2
Language English
License https://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c424t-16bd4e040a2a3065916f73dd6e3f6e974c52e3639e62f262e0d356b9d8a3c38b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7465-0880
0000-0001-6172-1483
0000-0002-8474-4976
OpenAccessLink https://www.proquest.com/docview/3090943722?pq-origsite=%requestingapplication%
PMID 39125805
PQID 3090943722
PQPubID 2032341
ParticipantIDs proquest_miscellaneous_3091288689
proquest_journals_3090943722
gale_infotracmisc_A804511428
gale_infotracacademiconefile_A804511428
pubmed_primary_39125805
crossref_citationtrail_10_3390_ijms25158235
crossref_primary_10_3390_ijms25158235
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2024
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References Yu (ref_17) 2011; 14
ref_36
ref_13
Zinman (ref_3) 2015; 373
Margonato (ref_12) 2021; 26
Cowie (ref_15) 2020; 17
ref_11
ref_10
ref_32
ref_31
Wanner (ref_4) 2016; 375
Lee (ref_18) 2019; 317
ref_19
Packer (ref_30) 2020; 383
Smogorzewski (ref_37) 1998; 53
ref_39
ref_38
Yang (ref_28) 2019; 513
Zelniker (ref_14) 2020; 75
Buse (ref_8) 2020; 63
Szepes (ref_40) 2013; 31
Verma (ref_16) 2018; 61
Heerspink (ref_5) 2020; 383
ref_25
ref_24
ref_23
ref_22
Suliman (ref_35) 2016; 68
ref_20
ref_41
ref_1
Perkovic (ref_7) 2019; 380
Tahrir (ref_34) 2019; 234
ref_2
ref_29
Agell (ref_21) 2002; 14
ref_27
Liu (ref_33) 2019; 23
ref_26
ref_9
Neal (ref_6) 2017; 377
References_xml – ident: ref_41
  doi: 10.3390/antiox10081223
– ident: ref_32
  doi: 10.14814/phy2.13741
– volume: 14
  start-page: 425
  year: 2011
  ident: ref_17
  article-title: High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2010.3284
– ident: ref_22
  doi: 10.1016/j.biopha.2021.112455
– volume: 75
  start-page: 422
  year: 2020
  ident: ref_14
  article-title: Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2019.11.031
– ident: ref_31
  doi: 10.1186/s12933-022-01532-6
– volume: 31
  start-page: 26
  year: 2013
  ident: ref_40
  article-title: Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2012.1186
– ident: ref_10
  doi: 10.3390/cells8091085
– volume: 61
  start-page: 2108
  year: 2018
  ident: ref_16
  article-title: SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review
  publication-title: Diabetologia
  doi: 10.1007/s00125-018-4670-7
– volume: 317
  start-page: F767
  year: 2019
  ident: ref_18
  article-title: Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
  publication-title: Am. J. Physiol. Renal Physiol.
  doi: 10.1152/ajprenal.00565.2018
– ident: ref_23
  doi: 10.3390/cells11193107
– ident: ref_27
  doi: 10.3390/ijms232213816
– volume: 383
  start-page: 1413
  year: 2020
  ident: ref_30
  article-title: Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2022190
– volume: 513
  start-page: 154
  year: 2019
  ident: ref_28
  article-title: High-glucose induces cardiac myocytes apoptosis through Foxo1/GRK2 signaling pathway
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2019.03.193
– ident: ref_39
  doi: 10.1038/s41598-020-76698-8
– ident: ref_1
  doi: 10.1002/advs.202100275
– ident: ref_36
  doi: 10.3389/fphys.2020.00252
– volume: 380
  start-page: 2295
  year: 2019
  ident: ref_7
  article-title: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1811744
– ident: ref_2
  doi: 10.1016/j.diabres.2019.107843
– volume: 14
  start-page: 649
  year: 2002
  ident: ref_21
  article-title: Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin
  publication-title: Cell Signal.
  doi: 10.1016/S0898-6568(02)00007-4
– ident: ref_38
  doi: 10.3390/ijms20071680
– volume: 377
  start-page: 644
  year: 2017
  ident: ref_6
  article-title: Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1611925
– ident: ref_20
  doi: 10.1186/s12933-023-01756-0
– volume: 373
  start-page: 2117
  year: 2015
  ident: ref_3
  article-title: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1504720
– ident: ref_13
  doi: 10.1007/s11886-019-1165-1
– ident: ref_25
  doi: 10.3389/fcvm.2022.859253
– volume: 23
  start-page: 798
  year: 2019
  ident: ref_33
  article-title: Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/jcmm.13975
– ident: ref_19
  doi: 10.1155/2022/1122494
– volume: 26
  start-page: 337
  year: 2021
  ident: ref_12
  article-title: Renal protection: A leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
  publication-title: Heart Fail. Rev.
  doi: 10.1007/s10741-020-10024-2
– volume: 383
  start-page: 1436
  year: 2020
  ident: ref_5
  article-title: Dapagliflozin in Patients with Chronic Kidney Disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2024816
– volume: 234
  start-page: 8122
  year: 2019
  ident: ref_34
  article-title: Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease
  publication-title: J. Cell Physiol.
  doi: 10.1002/jcp.27597
– ident: ref_26
  doi: 10.3389/fcvm.2023.1005408
– volume: 375
  start-page: 323
  year: 2016
  ident: ref_4
  article-title: Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1515920
– volume: 63
  start-page: 221
  year: 2020
  ident: ref_8
  article-title: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
  publication-title: Diabetologia
  doi: 10.1007/s00125-019-05039-w
– ident: ref_11
  doi: 10.1016/j.metabol.2020.154334
– ident: ref_29
  doi: 10.3390/cells9071662
– ident: ref_24
  doi: 10.1016/j.cellsig.2019.109506
– volume: 53
  start-page: 1237
  year: 1998
  ident: ref_37
  article-title: High glucose concentration causes a rise in [Ca2+]i of cardiac myocytes
  publication-title: Kidney Int.
  doi: 10.1046/j.1523-1755.1998.00868.x
– ident: ref_9
  doi: 10.1016/j.kint.2020.06.019
– volume: 17
  start-page: 761
  year: 2020
  ident: ref_15
  article-title: SGLT2 inhibitors: Mechanisms of cardiovascular benefit beyond glycaemic control
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-020-0406-8
– volume: 68
  start-page: 20
  year: 2016
  ident: ref_35
  article-title: Mitochondrial Quality Control as a Therapeutic Target
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.115.011502
SSID ssj0023259
Score 2.4365628
Snippet A previous study showed that high-glucose (HG) conditions induce mitochondria fragmentation through the calcium-mediated activation of extracellular...
SourceID proquest
gale
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 8235
SubjectTerms Animals
Antidiabetics
Apoptosis
Apoptosis - drug effects
Benzhydryl Compounds - pharmacology
Blood vessels
Calcium - metabolism
Caspase 3 - metabolism
Cell Line
Cell Survival - drug effects
Dextrose
Diabetes
Glucose
Glucose - metabolism
Glucosides - pharmacology
Kidneys
Kinases
MAP Kinase Signaling System - drug effects
Mitochondria
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondrial Dynamics - drug effects
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3 - metabolism
Oxidative stress
Proteins
Quantitative analysis
Rats
Scientific equipment and supplies industry
Type 2 diabetes
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nj9MwELVgERIXxDdZFmQkEAdkNbUdJzmhqnSpQIsQy0q9RY7tVEFpUjapluUf8q-YSdyWXQlOOdiJkoxn5k38Mo-QV1BtKRMWisVJETPpQsO0k4oZaVSexyaV_XbByWc1P5MfF9HCf3BrPa1yGxP7QG0bg9_IRyJMkQQXc_5u_YOhahTurnoJjZvkFrYuQ0pXvNgXXIL3YmljyEFMRakaiO8CyvxR-X3VQmqPEt4Lve1T0vXAfA1u9mnn-B656_EinQwGvk9uuPoBuT0oSF4-JL9n4M7Lqiyq5ldZU9-QiSJ7g30Y2Oj0tCtXXqSLolKHgWxFJ-tm3TVt2VJdW3oCfg1xsLawHClg2eXK_5JUU7jqPJ1yOnVV1VIv6wNHR6e6MuVmxd57Hd2OTsxWLI3OfnbnGncFkOZKT8slPAX7OgjfO0s_lTWkTzoecfoFMOiFvnxEzo5n36Zz5tUZwI5cdmyscgu2laHmGuXnAWcWsbBWOVEoB2WKibgTAICc4gVX3IVWRCpPbaKFEUkuHpODuqndU0JNONZGFTK1-aBoKQstk8JEGCDA6AF5uzVQZnzrclTQqDIoYdCc2d_mDMjr3ez10LLjH_PeoK0z9GR8Jdr_kAD3hD2xskmCvXewI11Ajq7MBA80V4e3qyXzEaDN9us1IC93w3gmstpq12z6OQAPEpWkAXkyrLLdHQsYipIwOvz_xZ-ROxxg1kBJPCIH3fnGPQeY1OUvel_4Ax5OEm4
  priority: 102
  providerName: ProQuest
Title Empagliflozin Prevent High-Glucose Stimulation Inducing Apoptosis and Mitochondria Fragmentation in H9C2 Cells through the Calcium-Dependent Activation Extracellular Signal-Regulated Kinase 1/2 Pathway
URI https://www.ncbi.nlm.nih.gov/pubmed/39125805
https://www.proquest.com/docview/3090943722
https://www.proquest.com/docview/3091288689
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELb2ISQuiDeBpTISiAMKm9qOkxwQKqXdCtTVapdKvUWO41RBaVKaVGz5h_wrZvKo6AISl-RgJ7I9M55v4sl8hLyEaEtqJ5G25yeeLYyjbWWEtLXQMoo8HYj6uGB6Licz8Wnuzg9IxzbaLmD519AO-aRm6-zt9bftezD4dxhxQsh-mn5dluCmXZ9x95Acg0_y0ESnYneeALChpk3DDx42btBNCvwfT-85p5tb9A3gWTug8V1yp0WOdNCI-h45MPl9cqvhktw-ID9HYNiLLE2y4kea07Y0E8U8DvusyUunV1W6bOm6KHJ2aPBbdLAqVlVRpiVVeUynYOGwKHkMikkB1S6W7c9JOYW3ToIho0OTZSVtCX7gbuhQZTrdLO2PLaNuRQe6o02jo-tqrfB8ABNe6VW6gFnYl2aBAzEx_Zzm4Ehp_5TRC0Cj39X2IZmNR1-GE7vlaQCJMlHZfRnFIGXhKKaQiB4QZ-LxOJaGJ9JAwKJdZjhAISNZwiQzTsxdGQWxr7jmfsQfkaO8yM0TQrXTV1omIoijhttSJEr4iXZxqwgEt8ibTkChbouYI5dGFkIwg-IMfxenRV7teq-a4h3_6PcaZR2iluGSqPbXBBgTVscKBz5W4cHadBY52esJtqj3mzttCTtVDrkTYPqmx5hFXuya8UnMb8tNsan7AFDwpR9Y5HGjZbsRc2hyfcd9-p-zeUZuM0BeTZbiCTmq1hvzHJBTFfXIoTf34OqPz3rk-MPo_OKyh77M7dXm8guP7hwT
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIIXxJ2OAUZi4gFZTe3ESR4QqrqOjq4TYpvUt-A4TpUpTcqSapQfxf_gX3FOLi2bBG97yoMdx8m5fY6Pz0fIW1htSW3Fkrle7DLbWJopY0umbS3D0NW-XW0XTI7l6Mz-PHWmW-RXexYG0ypbn1g56ijX-I-8Kywfk-Bczj8uvjNkjcLd1ZZCo1aLsVldwpKt-HC4D_Ld4_xgeDoYsYZVAJ7P7ZL1ZBjBnGxLcYW06YCPYldEkTQilgbgtXa4ERC4jeQxl9xYkXBk6EeeElp4oYBxb5HbEHgttCh3ulngCV6Rs_Ug5jEYWNaJ9kL4Vjc5nxcAJRyPV8RymxB4PRBcg7dVmDt4QO43-JT2a4V6SLZM9ojcqRkrV4_J7yG4j1maxGn-M8loUwCKYrYI-1Rnv9OTMpk3pGAUmUE0REfaX-SLMi-SgqosohPwI-B3swjUnwJ2ns2bI1AZhVFH_oDTgUnTgjY0QnA1dKBSnSznbL_h7S1pX7fkbHT4o7xQuAuBabX0JJnBW7CvZoYTMREdJxmEa9rrcvoFMO-lWj0hZzcit6dkO8sz85xQbfWUlrHtR2HNoGnHyvZi7aBDAiXrkPetgALdlEpHxo40gCUTijP4W5wdsrfuvahLhPyj3zuUdYCeAz-Jag5AwJywBlfQ97DWD1bA65DdKz3B4vXV5lZbgsbjFMHGPjrkzboZ78Qsuszky6oPwBFPen6HPKu1bD1jAU2OZzk7_x_8Nbk7Op0cBUeHx-MX5B4HiFenQ-6S7fJiaV4CRCvDV5VdUPLtpg3xD5MvTlM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIgXxJ3CACMx8YCspnbiJA8IVb3QUTZNjEl9yxLHqYLSpCypRvlp_AP-FeckTssmwdue8mDXOum5fY6Pz0fIG9htSWUlkrle4jJbW4qF2pZM2UpGkat8uz4uODySk1P708yZ7ZBf7V0YLKtsY2IdqONC4TfyrrB8LIJzOe8mpizieDj-sPzOkEEKT1pbOo3GRKZ6fQHbt_L9wRB0vc_5ePR1MGGGYQBk4XbFejKKQT7bCnmIFOqAlRJXxLHUIpEaoLZyuBaQxLXkCZdcW7FwZOTHXiiU8CIB694gN13h9NDH3Nl2syd4TdTWg_zHYGHZFN0L4Vvd9NuiBFjheLwmmdumw6tJ4QrUrVPe-B65a7Aq7TfGdZ_s6PwBudWwV64fkt8jCCXzLE2y4meaU9MMimLlCPvYVMLTkypdGIIwiiwhCjIl7S-LZVWUaUnDPKaHEFMgBucxuAIFHD1fmOtQOYVVJ_6A04HOspIaSiF4ajoIM5WuFmxoOHwr2lctURsd_ajOQzyRwBJbepLO4S3YFz1HQXRMp2kOqZv2upweA_69CNePyOm16O0x2c2LXD8lVFm9UMnE9uOoYdO0k9D2EuVgcAKD65B3rYICZdqmI3tHFsD2CdUZ_K3ODtnfzF427UL-Me8t6jrAKIJ_SWguQ4BM2I8r6HvY9we74XXI3qWZ4P3q8nBrLYGJPmWw9ZUOeb0Zxl9iRV2ui1U9B6CJJz2_Q540VraRWMCQ41nOs_8v_orcBhcMPh8cTZ-TOxzQXlMZuUd2q_OVfgForYpe1m5Bydl1--EfHLNSiQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Empagliflozin+Prevent+High-Glucose+Stimulation+Inducing+Apoptosis+and+Mitochondria+Fragmentation+in+H9C2+Cells+through+the+Calcium-Dependent+Activation+Extracellular+Signal-Regulated+Kinase+1%2F2+Pathway&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Chen%2C+Yung-Lung&rft.au=Wang%2C+Hui-Ting&rft.au=Lee%2C+Wen-Chin&rft.au=Lin%2C+Pei-Ting&rft.date=2024-08-01&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=25&rft.issue=15&rft.spage=8235&rft_id=info:doi/10.3390%2Fijms25158235&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms25158235
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon